Meet the inlaws： Embryonic stem cell derivatives meet the immune system  

作　　者：William B Tabayoyong Nicholas Zavazava 

机构地区：[1]Immunology Graduate Program, University of Iowa, 200 Hawkins Drive, C42 E6 GH, Iowa City, Iowa 52242, USA [2]Department of lnternal Medicine, University of Iowa and Veteran Affairs Medical Center, Iowa City, Iowa 52242, USA

出　　处：《Cell Research》2009年第4期397-398,共2页细胞研究（英文版）

摘　　要：Since the derivation of embryonic stem （ES） cell lines from human blastocysts in 1998 [1], ES cells have emerged as a potential source of cells and tissues that could be used for cell replacement therapy of incurable degenerative diseases. This is due to their remarkable pluripotency, which enables them to differentiate into any adult cell type of the three embryonal germ layers. Indeed, several groups have reported the successful differentiation of ES cells into adult-type cell lineages including, but not limited to： cardiomyocytes, hematopoietic cells, hepatocytes,

关 键 词：胚胎干细胞 免疫系统 衍生 退行性疾病 成熟细胞 心肌细胞 造血细胞 细胞系 

分 类 号：Q813[生物学—生物工程] S852.4[农业科学—基础兽医学]